SXTP 60 DEGREES PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1946563 · EDGAR
- Bought, last 12 months
- $30.1K 3 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 27 since 2023-07-12, latest 2026-06-15 16:50
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| DOW GEOFFREY S | Pres, CEO, Dir | $30.1K | — |
Transactions 23
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 16:50 | 2026-06-12 | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | P - Purchase | $1.38 | +7,350 | 24.1K | +44% | +$10.1K | |
| 2025-12-16 | 2025-12-15 | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | P - Purchase | $0.8 | +9,670 | 59.6K | +19% | +$7,736 | |
| M | 2025-12-12 | 2025-12-10+ | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | P - Purchase | $0.9416 | +13.0K | 46.3K | +39% | +$12.2K |
| 2025-09-15 | 2025-09-12 | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | A - Grant | $1.39 | +7,201 | 33.4K | +28% | +$10.0K | |
| 2025-08-14 | 2025-01-17 | SXTP | Landon Kristen | COO | A - Grant | $0.00 | +4,540 | 4,540 | New | $0 | |
| 2025-06-09 | 2025-06-09 | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | A - Grant | $2.99 | +4,376 | 26.2K | +20% | +$13.1K | |
| M | 2025-06-05 | 2025-06-03 | SXTP | XU CHERYL | Dir | P - Purchase | $2.88 | +5,000 | 13.8K | +57% | +$14.4K |
| 2025-01-21 | 2025-01-17 | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | A - Grant | $0.00 | +14.4K | 109.0K | +15% | $0 | |
| 2025-01-21 | 2025-01-17 | SXTP | MILLER TYRONE | CFO | A - Grant | $0.00 | +11.6K | 26.4K | +79% | $0 | |
| M | 2024-12-18 | 2024-12-12+ | SXTP | XU CHERYL | Dir | P - Purchase | $1.65 | +13.0K | 46.1K | +39% | +$21.4K |
| M | 2024-12-09 | 2024-12-05+ | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | P - Purchase | $1.21 | +74.0K | 94.6K | +358% | +$89.7K |
| M | 2024-11-21 | 2024-11-19+ | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | P - Purchase | $0.9079 | +7,000 | 17.1K | +69% | +$6,355 |
| 2024-09-11 | 2024-08-27 | SXTP | XU CHERYL | Dir | P - Purchase | $1.70 | +5,000 | 41.1K | +14% | +$8,500 | |
| DM | 2024-05-21 | 2024-04-12+ | SXTP | MILLER TYRONE | CFO | A - Grant | $0.26 | +75.0K | 161.9K | +86% | +$19.5K |
| D | 2024-05-21 | 2024-05-16 | SXTP | XU CHERYL | Dir | M - OptEx | $0.22 | +2,000 | 228.9K | +0.9% | +$440 |
| D | 2024-05-21 | 2024-05-16 | SXTP | FIELD PAUL | Dir | M - OptEx | $0.22 | +4,000 | 14.0K | +40% | +$880 |
| D | 2024-05-21 | 2024-05-16 | SXTP | Allen Charles W | Dir | M - OptEx | $0.22 | +4,000 | 14.0K | +40% | +$880 |
| DM | 2024-05-21 | 2024-04-12+ | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | M - OptEx | $0.26 | +85.0K | 745.6K | +13% | +$22.1K |
| D | 2024-05-21 | 2024-05-16 | SXTP | TOOVEY STEPHEN | Dir | A - Grant | $0.22 | +4,000 | 14.0K | +40% | +$880 |
| MI | 2024-04-03 | 2023-07-28 | SXTP | KNIGHT THERAPEUTICS INTERNATIONAL SA | Former 10% Owner | C - Cnv Deriv | $4.53 | +43.4K | 1.15M | +4% | +$196.8K |
| D | 2024-02-02 | 2024-01-31 | SXTP | XU CHERYL | Dir | P - Purchase | $0.38 | +200.0K | 424.9K | +89% | +$76.0K |
| D | 2024-02-02 | 2024-02-01 | SXTP | XU CHERYL | Dir | M - OptEx | — | +2,000 | 6,000 | +50% | — |
| D | 2024-02-02 | 2024-01-31 | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | P - Purchase | $0.38 | +26.0K | 703.6K | +4% | +$9,870 |
Purchase Sale Sale after option exercise All abbreviations